Published • loading... • Updated
Alzheimer's blood test could 'revolutionise' diagnosis
The trial involving 1,100 UK patients evaluates a £100 blood test measuring p-tau217 to improve early Alzheimer's diagnosis and support timely treatment access within the NHS.
- Medical professionals in Britain have started a clinical study to test a £100 blood test for diagnosing Alzheimer's, enrolling over 1,000 individuals experiencing potential dementia symptoms from memory centres across the UK.
- The blood test measures p-tau217, a protein associated with Alzheimer's, aiming to enhance diagnostic speed and treatment plans, supported by the Blood Biomarker Challenge.
- Participants will receive test results either within three months or after twelve months, allowing researchers to evaluate the impact of expedited results on diagnosis and patient management.
- Prof Jonathan Schott of University College London stated the initiative could modernize dementia care and improve the NHS's readiness for emerging treatments over the next decade.
Insights by Ground AI
Podcasts & Opinions
41 Articles
41 Articles
UK launches breakthrough Alzheimer's blood test trial for NHS use
A groundbreaking UK clinical trial led by UCL aims to revolutionise Alzheimer’s diagnosis using a simple blood test The ADAPT (Alzheimer’s Disease Diagnosis and Plasma pTau217) team, led by Professor Jonathan Schott and Dr. Ashvini Keshavan, is investigating whether a blood test that measures the protein p-tau217 can enhance the early and accurate diagnosis of Alzheimer’s disease. The landmark trial is part of the Blood Biomarker Challenge, an i…
A clinical trial in the UK will be launched to evaluate the effectiveness of blood tests to improve and accelerate the diagnosis of Alzheimer's disease.
·France
Read Full Article
Coverage Details
Total News Sources41
Leaning Left7Leaning Right7Center17Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
55% Center
L 23%
C 55%
R 22%
Factuality
To view factuality data please Upgrade to Premium
